Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Study, Assessing Multiple LNP023 Doses in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria
Clinical trial NCT03896152 · COMPLETED
Trial details
- NCT number
- NCT03896152
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-05
- Primary completion
- 2020-04-07
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.